Risk factors for fluid retention associated with clazosentan after subarachnoid hemorrhage: a retrospective study
Older age and early fluid accumulation emerged as significant risk factors for fluid retention in patients treated with clazosentan. In older individuals, close monitoring and careful fluid balance management may help prevent clazosentan-associated complications.
Authors
- Toru Imai (ORCID: https://orcid.org/0000-0002-8648-7571)
- Yutaka Suzuki (ORCID: https://orcid.org/0000-0002-2603-5688)
- Masao Sekimoto (ORCID: https://orcid.org/0000-0001-9895-6059)
- Shingo Ihara (ORCID: https://orcid.org/0000-0002-2963-415X)
- Naoki Otani
- Nobutaka Chiba
Institutions
- Nihon University (JP)
- Nihon University Itabashi Hospital (JP)
Publication Details
- Journal
- Neurological Research
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1080/01616412.2025.2571954
- Primary Topic
- Intracranial Aneurysms: Treatment and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00